Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Alliance, apoptotic, Australia, Biology, CBCA, compelling, conference, convenience, country, diagnosed, Director, discourage, ESH, Estoril, failure, featured, Fed, frontline, fully, growing, Haematology, Houston, Institutional, irrevocable, Korean, lethal, naive, newly, Notably, ORR, parental, party, payable, perpetual, phosphokinome, population, Portugal, pro, proteome, rapidly, reorganization, salvage, software, Spain, staggered, subscription, tablet, tiered, tranche, Translational, unusually, upfront, vulnerability
Removed:
base, comprising, declared, distribute, filing, shelf, short, voting
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view